NCT06801041View on ClinicalTrials.gov

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 23, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2029

Conditions
DepressionAnxietyCancer
Interventions
DRUG

Psilocybin

Participants will recive treatment by mouth on an outpatient basis.

Trial Locations (1)

77030

RECRUITING

The University of Texas M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT06801041 - TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors | Biotech Hunter | Biotech Hunter